about
Ventricular tachycardia score - A novel method for wide QRS complex tachycardia differentiation - Explained.Short-coupled variant of torsade de pointes - an important cause of syncope and sudden death.The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases.24-hour central blood pressure and intermediate cardiovascular phenotypes in untreated subjects.Left ventricular diastolic function associated with common genetic variation in ATP12A in a general population.Baseline tissue Doppler imaging-derived echocardiographic parameters and left ventricle reverse remodelling following cardiac resynchronization therapy introduction.A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of PolandTransvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failureEchocardiographic assessment of right ventricular function in responders and non-responders to cardiac resynchronization therapyCardiac Rehabilitation in Real Life.The challenge of blood pressure control in patients with ischaemic heart disease in Europe.Association of free testosterone and sex hormone binding globulin with metabolic syndrome and subclinical atherosclerosis but not blood pressure in hypertensive perimenopausal womenJoint position statement of the Polish Cardiologic Society, the Polish Gynaecological Society and the Polish Menopause and Andropause Society on the effect of postmenopausal hormone replacement therapy on the cardiovascular system.Transient cortical blindness after coronary artery angiography.Rescue percutaneous coronary recanalization of right coronary artery by retrograde approach.Inflammatory markers 10 weeks after myocardial infarction predict future cardiovascular events.[Impact of chronic Chlamydia pneumoniae infection on left ventricular remodeling after myocardial infarction].Sodium and potassium and the pathogenesis of hypertension.Myocardial infarction caused by pharmacological substances - case description and literature reviewVitamin D and vitamin D receptor activators in treatment of hypertension and cardiovascular disease.Will Sodium Intake Reduction Improve Cardiovascular Outcomes in the General Population? A Critical Review of Current Evidence.The risk of diabetes development in long-term observation of patients with acute hyperglycaemia during myocardial infarction.Relationship between past myocardial infarction, periodontal disease and Porphyromonas gingivalis serum antibodies: A case-control study.Effects of device‑guided slow breathing training on exercise capacity, cardiac function, and respiratory patterns during sleep in male and female patients with chronic heart failure.Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006?Assessment of sleep disorders among patients with hypertension and coexisting metabolic syndrome.Relationships of insulin-like growth factor-1, its binding proteins, and cardiometabolic risk in hypertensive perimenopausal women.Relationship between gender and clinical characteristics, associated factors, and hypertension treatment in patients with resistant hypertension.Blood pressure changes in patients with chronic heart failure undergoing slow breathing training.Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.Chronic total occlusion in ostium of right coronary artery - retrograde approach as the first-choice method of revascularization?Adipocytokines and blood pressure, lipids and glucose metabolism in hypertensive perimenopausal women.Erratum to: A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland.Dedicated devices and techniques - a cornerstone in recanalisation of chronic total occlusions of coronary arteries.Comparison of cardiac and gastric responses to vagal stimulation in hypertensive women.Structure and function of large arteries in hypertension in relation to oxidative stress markers.Twenty-four-hour profile of central blood pressure and central-to-peripheral systolic pressure amplification.Insulin resistance and lipids in hypertensive women on hormone replacement therapy.Electrocardiographic patterns during left ventricular epicardial pacing.Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
P50
Q30401983-7E8F0755-8E3E-4E14-BF62-819C3628F255Q33163926-7151EB02-6054-4761-BB9B-ACCE9AB169CDQ33904413-ED647D6C-751D-4189-9900-1AEBB4A93443Q34987397-04CE8AA1-EF13-4EBA-86AF-789C7678A3EDQ35388910-CF6BF70D-D576-4FC2-AEA3-BE5CB864DBC3Q35674350-BE3130B5-C400-402C-A875-F6E30BA8A9A7Q35848502-B9CD4B14-55ED-4A46-8448-29AF3A72CA73Q35937810-E8762355-FA8E-4B04-8EC3-4D7103EF251CQ35992118-54F3A065-1A8A-4F1C-9411-AFFCFCE8E7F1Q36195105-DE41A08A-C2DB-4DD2-8125-AB70A6D0FD2FQ36375097-6BEA6331-B82A-441C-A326-7A6CE09D8E56Q36958261-93F843BB-A93C-4DDC-81FB-A9E520ED7640Q37196548-4594A27A-6B7A-4D7D-812C-8706B95E3EF6Q37561822-5A704DA4-E497-42FB-9FD4-8313DFD41AA7Q37561871-5490881F-B6CF-4FB1-A0AA-1B3357D1BA63Q37856998-A6DA00CA-4C30-4DE5-814B-5B2C2FFE9AD1Q37859394-894AA3B6-66B7-43D0-9138-F469B4798C97Q38080458-ED2705AC-9472-4666-A4C0-9C17C2A7CB89Q38191218-E2DE5585-3F07-4005-9343-F1FCED7CF6CAQ38193542-A86EBB0F-5DCA-460B-9670-145B8EAE0A36Q38509593-9A12FC94-5FE9-47AB-8E84-433FAB5A19FEQ38970485-4B2A667F-1447-4BA3-BB89-28F710900F24Q38984544-DEF26EF3-0A38-411A-94C0-631C50AABA6AQ39027371-44DAD163-303C-406F-82FC-E58A7BE0A526Q39275815-DEBBCDB2-75A6-4696-AA56-6861CD0E5E92Q39814029-8297E6F7-6C19-4DE5-BA0F-F68F06984720Q40295926-D6207770-9842-41B7-90D6-32C0CBE310F3Q40354734-997FDB0A-DF25-4A93-B7E4-4928E94D8CC1Q40379760-CC4B0F03-9783-4D38-9BA7-5A6E8E77087AQ41263966-F291392F-499D-4955-9A6C-872D39A2C482Q41961236-360511C7-1341-4DB0-BD0A-6FCD0F317A0EQ42963133-DAF1E51C-DFE3-4F4C-B898-5D7EB594EF9CQ42976328-2F950803-B0A1-4F54-B802-8ECAF7C96AFBQ43051118-042A8376-06F5-48B6-AAF7-126524CCC60EQ43269491-370C3B1D-8FDB-423E-B75B-61DE41940DD0Q43707520-E9739A13-6745-4441-ADB1-E02557429E61Q43794768-8B45F63C-2A2E-455A-88A7-9B5C3C446FD6Q43942254-CCCC76D0-FFFE-48AA-8674-1613068C0774Q44274746-16ED93BB-9870-4382-BB1C-905FDAA671B8Q44365619-7E237EFD-DAD7-49FE-A5A2-EB78E2DF748D
P50
description
Polish cardiologist
@en
Pools onderzoekster
@nl
polska lekarka, kardiolog
@pl
name
Danuta Czarnecka
@ast
Danuta Czarnecka
@ca
Danuta Czarnecka
@cs
Danuta Czarnecka
@en
Danuta Czarnecka
@es
Danuta Czarnecka
@ga
Danuta Czarnecka
@gl
Danuta Czarnecka
@hr
Danuta Czarnecka
@hsb
Danuta Czarnecka
@it
type
label
Danuta Czarnecka
@ast
Danuta Czarnecka
@ca
Danuta Czarnecka
@cs
Danuta Czarnecka
@en
Danuta Czarnecka
@es
Danuta Czarnecka
@ga
Danuta Czarnecka
@gl
Danuta Czarnecka
@hr
Danuta Czarnecka
@hsb
Danuta Czarnecka
@it
altLabel
Danuta Maria Czarnecka
@pl
prefLabel
Danuta Czarnecka
@ast
Danuta Czarnecka
@ca
Danuta Czarnecka
@cs
Danuta Czarnecka
@en
Danuta Czarnecka
@es
Danuta Czarnecka
@ga
Danuta Czarnecka
@gl
Danuta Czarnecka
@hr
Danuta Czarnecka
@hsb
Danuta Czarnecka
@it
P214
P1053
U-4296-2018
P106
P1153
7004182504
P1412
P1559
Danuta Czarnecka
@pl
P21
P214
P27
P31
P496
0000-0002-6388-112X
P735
P7859
viaf-101636580